Home › Funds › Veritas Asset Management LLP › ELV

Veritas Asset Management LLP position in ELV

ELEVANCE HEALTH INC FORMERLY · Health Care

Veritas Asset Management LLP reported holding 428,672 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q2 2026 13F filing — a position valued at US$165.8M, representing 2.98% of its reported portfolio and ranking #16 among its reported holdings. Veritas Asset Management LLP has disclosed ELV holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)428.67K sh
Reported value held$165.78M
Portfolio Weight2.98%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Veritas Asset Management LLP's ELV position evolved

Veritas Asset Management LLP first disclosed a stake in ELV in Q3 2023 at 1,201,789 shares (US$523.3M). The position peaked in Q2 2024 at 1,137,062 shares, worth US$616.1M. Across 12 filings, Veritas Asset Management LLP increased the stake 0 time(s), trimmed it 11 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 428,672 shares valued at US$165.8M — a reduction of -206,699 shares quarter over quarter.. Notable position changes include a 27% trim in Q1 2026 (shares rose 33% over the following quarter), a 33% trim in Q2 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.20M $523.28M New
Q4 2023 1.17M $552.63M Reduce
Q1 2024 1.16M $601.50M Reduce
Q2 2024 1.14M $616.13M Reduce
Q3 2024 1.10M $570.84M Reduce
Q4 2024 986.74K $364.01M Reduce
Q1 2025 952.90K $414.47M Reduce
Q2 2025 913.36K $355.26M Reduce
Q3 2025 902.90K $291.75M Reduce
Q4 2025 873.99K $306.38M Reduce
Q1 2026 635.37K $186.00M Reduce
Q2 2026 428.67K $165.78M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELV and 13F data

ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 23 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.56B), Sanders Capital, LLC (US$2.25B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELV

All ELV fund holders →

FAQ

How long has Veritas Asset Management LLP held ELV?

Veritas Asset Management LLP has disclosed ELV holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Veritas Asset Management LLP's current position in ELV?

As of Q2 2026, Veritas Asset Management LLP holds 428.67K shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $165.78M, representing 2.98% of its reported portfolio and ranking #16.

Has Veritas Asset Management LLP been buying or selling ELV?

In the latest 13F filing (Q2 2026), Veritas Asset Management LLP reduced its position in ELV. The position peaked in Q2 2024 at 1.14M shares.

Which other funds hold ELV?

Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.